IRVINE, Calif.--(BUSINESS WIRE)--Cortex Pharmaceuticals, Inc. (NYSE Alternext US (COR), http://www.cortexpharm.com) reported a net loss of $3,148,000, or $0.07 per share for the quarter ended September 30, 2008 compared with a net loss of $2,962,000, or $0.07 per share for the corresponding prior year period. Non-cash stock-based compensation charges for the quarters ended September 30, 2008 and 2007 totaled approximately $317,000 and $635,000, respectively.
